Rznomics Inc
476830
Company Profile
Business description
Rznomics Inc is engaged in research and development of biopharmaceuticals, developing gene therapy drugs based on RNA substitution enzyme platform and self-cycling RNA platform technologies, and commercializing them through technology transfer.
Contact
Pangyo Innovalley, 253 Pangyo-ro
801, C Building
Bundang-gu
Gyeonggi-do
Seongnam-si
KORT: +82 317068730
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
40
Stocks News & Analysis
stocks
Cheap e-commerce share continues sales momentum
The e-commerce business continues its sales momentum despite challenging backdrop.
stocks
Chart of the Week: Booming mined commodity prices see little value on offer
Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,819.60 | 65.10 | -0.73% |
| CAC 40 | 8,188.87 | 19.02 | -0.23% |
| DAX 40 | 25,092.25 | 85.55 | -0.34% |
| Dow JONES (US) | 50,619.27 | 25.01 | -0.05% |
| FTSE 100 | 10,425.96 | 79.05 | -0.75% |
| HKSE | 25,006.16 | 322.07 | -1.27% |
| NASDAQ | 26,898.95 | 224.22 | 0.84% |
| Nikkei 225 | 64,693.12 | 306.29 | -0.47% |
| NZX 50 Index | 13,206.11 | 21.70 | -0.16% |
| S&P 500 | 7,559.36 | 39.00 | 0.52% |
| S&P/ASX 200 | 8,592.90 | 61.60 | -0.71% |
| SSE Composite Index | 4,098.64 | 4.91 | 0.12% |